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Abstract
Background: Anticholinergic drugs in elderly people have been associated with some serious side-effects. Patients 
in Turkey tend to attend primary care centers to have prescriptions of the drugs they chronically use. However, very 
little are known about how frequent that these drugs are prescribed and their side-effects in Turkish population. We 
aimed to investigate the usage and side-effects of drugs with anticholinergic properties in patients over 65 years of 
age attending to primary care centers.
Materials and Methods: Five hundred and sixty-three subjects were interviewed with a questionnaire of 16 questions 
inquiring their medication and possible side-effects. Timed up and go test (TUGT) and standardized mini-mental 
test (SMMT) were also performed.
Results: Medical records of 563 individuals were screened to detect anticholinergic medication. Twenty-eight patients 
were using anticholinergic medication. Mean duration of anticholinergic medication usage was 3.17 years. Mean number 
of falls occurred in the previous year was 1.14 ± 1.17. Mean SMMT score was 27.20 ± 1.13. Mean TUGT scores mean 
was 12.4 ± 1.25. Drowsiness in 18 patients (65%), dry mouth in 15 patients (53%), dry eyes in 15 patients (53%), 
constipation in 11 patients (39%), blurred vision in 11 patients (%39), urinary hesitancy in eight patients (28%), confusion 
in six patients (21%) were reported. We found that none of the subjects were evaluated in terms of fall risk or mental 
status by their doctors before the prescription of drugs with anticholinergic effects.
Conclusions: A suggested approach to improve drug safety was reported as to reduce the use of anticholinergic drugs 
when it is possible. Psychiatrists and family physicians should select less anticholinergic drugs for medication and have 
to evaluate their patients’ fall risk and their cognitive status before prescribing drugs with anticholinergic side effects.
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Introduction
An adverse reaction is described as any reaction of the drug, 
which gives harm to a patient.
Such reactions can be seen with any drug use and variations 
of drugs’ adverse reactions can be seen in different patients. 
As they could be encountered in 5.3% of all admissions 
to hospital, the adverse drug reactions are accepted as an 
important health issue.[1]
Due to the changes in metabolism and excretion, age is an 
important factor, which can affect the response to drugs. 
As elderly people can experience higher frequency of 
adverse effects to medications, many of such affects could 
be avoided or could be reduced.[2]
The growing percentage of advanced age group 
affects health systems both socially and financially.[3] 
Polypharmacy is a major concern in elderly patients. 
Increasing numbers of chronic diseases in old age leads 
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to polypharmacy and polypharmacy leads to multiple side 
effects of the drugs.
Studies have reported that up to 20% of older adults were 
taking drugs with anticholinergic properties used for a wide 
variety of clinical disorders such as Parkinson’s disease, 
urinary incontinence, cardiovascular diseases, depression, 
allergy, gastrointestinal disorders, and psychosis.[4,5] 
Anticholinergic drugs in elderly people have been associated 
with side‑effects such as dry mouth, constipation, urinary 
retention or hesitancy, visual impairment, falls, confusion, 
drowsiness, delirium, and cognitive decline.[6‑10]
Anticholinergics were mentioned in Beers criteria which was 
updated in 2012; as drugs, which may cause dementia and 
cognitive impairment, delirium or constipation and have 
to be avoided in patients over 65 year old.[11] It was also 
mentioned in screening tool of older people’s potentially 
inappropriate prescriptions criteria as anticholinergics were 
potentially inappropriate medication to treat extrapyramidal 
side effects of neuroleptic medications due to risk of 
anti‑cholinergic toxicity.[12]
In Turkey, people tend to attend to primary care centers 
to see their family doctors to have prescriptions of the 
drugs they chronically use because they can much easily 
reach medical attention. Very little is known about how 
frequent that the drugs with anticholinergic properties 
are prescribed in primary care and their side‑effects in 
Turkish population.
Hence, we aimed to document usage and side‑effects of 
these drugs with anticholinergic side‑effects in patients 
over 65 years of age attending primary care.
Materials and Methods
Subjects over 65‑year of age who admitted to Afton 
5th Family Care Center, which serves 15,898 registered 
people with four family doctors were included into this study. 
8.6% of this population, 1848 people were over 65‑year 
of age. A total of 563 patients comprising 30.5% of all 
registered patients over 65‑year of age admitting to our 
family center between October 14, 2013 and December 14, 
2013 were consecutively recruited.
Ethical committee approval was held from Educational 
Department of Ministry of Health, Ankara. Informed 
consent was obtained from patients attending our survey. 
Each subject was interviewed with a questionnaire 
of 16 questions. Sociodemographic properties and 
side‑effects were questioned by seven questions. 
Side‑effects such as drowsiness, dry mouth, dry eyes, 
constipation, blurred vision, urinary hesitancy, and 
confusion were questioned. Furthermore, patients were 
questioned if they have fallen, while using drugs with 
anticholinergic side‑effects. Whether their doctors asked 
for their falls or evaluated their mental status was checked 
with two questions.
Timed up and go test (TUGT) and standardized mini 
mental test (SMMT) were performed in each subject for 
the evaluation of risk of falling and cognitive status. A score 
of 14 s or more was considered as a risk for fall in TUTG. 
A score of 25 points was hesitancy stated as cut‑off score 
for mild dementia.[13]
Results
Medical records of 563 individuals were screened to 
detect anticholinergic medication usage. Twenty eight 
patients were using anticholinergic medication. Twenty 
patients were male (71.4%), eight patients (28.6%) 
were female. Mean age was 71.32 ± 5.24 years (range 
65‑83 years).
Mean number of systemic diseases of subjects was; 
2.46 ± 1.17. Mean duration of anticholinergic medication 
usage was 3.17 years. Mean number of falls experienced in 
the previous year was 1.14 ± 1.17. Mean SMMT score was 
27.20 ± 1.13. Mean TUGT score was 12.4 ± 1.25.
Educational and marital status of patients was shown 
in Table 1. This data were consistent with Research of 
Population and Health in Turkey 2008 Report.[14]
Medications with anticholinergic side effects prescribed by 
psychiatrists and urologists were shown in Table 2. Reported 
side‑effects of anticholinergic drugs were listed in Table 3. 
Two questions were asked to determine physicians’ attention 
to prescribe these kinds of drugs. Subjects answered 100% 
as “no” to questions:
1. “Did your doctor ask whether you ever fall before 
prescribing your drug?”
2. “Did your doctor evaluate your mental status before 
prescribing your drug?”
Table 1: Educational and marital status of patients











Male (n=20) (28.5) 8 (40) 8 (40) 1 (5) 3 (15) 6 (21.4) 4 (14.2)
Female (n=8) (71.5) 7 (87) 1 (13) 12 (42.8) 6 (21.4)
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Discussion
In advanced age, patients’ increasing number of diseases 
and drug usage is a challenging obstacle for a quality life. 
Inappropriate medication of drugs makes this a complex 
situation in elderly patients, which elimination, excretion 
and metabolism of drugs deteriorated and intoxication 
may be inevitable with inappropriate drug medication. 
In a follow‑up of a cohort study, which have a total 
of 9,294 patients over 65‑year of age, inappropriate 
medication with anticholinergic properties was found 
to be associated with an increased risk of falling.[15] In 
our study, we found that mean TUGT scores were low, 
verifying this data.
Use of anticholinergic medications has been associated with 
acute[16‑19] and chronic cognitive impairment. The latter 
statement was proved in a research conducted with 13,004 
participants.[18] Our subjects’ SMMT scores were low, but 
they were just over the cut‑off score. The leading side‑effect 
in our survey was drowsiness. Drowsiness and blurred 
vision disrupt patient’s stability in the upright position. 
So the patients under the influence of these side‑effects 
of anticholinergic drugs have a tendency to fall. Studies 
about anticholinergic drugs found that these drugs were 
associated with increased risk of falling[20] and with acute 
and chronic cognitive impairment.[21‑23] Falls in elderly 
patients are a major cause of morbidity and mortality.[19,24]
As far as we know this are the first study specifically 
investigating anticholinergic adverse effects of medications 
used in old age in Turkish population. However, small size 
of the population and lack of randomization are important 
limitations of our study.
Antidepressants were the most frequently prescribed 
anticholinergic drugs in our study. Even if selective 
serotonin reuptake inhibitors (SSRI’s) were selected 
rather than tricyclic antidepressants (TCA’s) in older 
patients, two published data about different classes of 
antidepressants and falls documented that older people 
who use SSRIs might not be any safer than those who use 
TCAs.[16,17]
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14.	 Eryurt	MA,	Türkyılmaz	AS,	Koç	İ. Hacettepe University Institute of Population 
Studies Turkish Population and Health Study Report 2008;25. 
15. Berdot S, Bertrand M, Dartigues JF, Fourrier A, Tavernier B, Ritchie K, et al. 
Inappropriate medication use and risk of falls – A prospective study in a large 
community‑dwelling elderly cohort. BMC Geriatr 2009;9:30.
16. Carrière I, Fourrier‑Reglat A, Dartigues JF, Rouaud O, Pasquier F, 
Ritchie K, et al. Drugs with anticholinergic properties, cognitive decline, and 
dementia in an elderly general population: The 3‑city study. Arch Intern Med 
2009;169:1317‑24.
17. Boustani MA, Campbell NL, Munger S, Maidment I, Fox C. Impact of 
anticholinergics on the aging brain: A review and practical application. Aging 
Health 2008;4:311‑20.
18. Fox C, Richardson K, Maidment ID, Savva GM, Matthews FE, 
Smithard D, et al. Anticholinergic medication use and cognitive impairment 
in the older population: The medical research council cognitive function and 
ageing study. J Am Geriatr Soc 2011;59:1477‑83.
19. Ensrud KE, Blackwell TL, Mangione CM, Bowman PJ, Whooley MA, 
Bauer DC, et al. Central nervous system‑active medications and risk for falls 
in older women. J Am Geriatr Soc 2002;50:1629‑37.
20. Carnahan RM, Lund BC, Perry PJ, Pollock BG, Culp KR. The anticholinergic 
Table 2: ARS of drugs
ARS 1 (16) n (%) ARS 2 (14) n (%) ARS 3 (14, 15) n (%)
Essitalopram 14 (50) Paroxetine 2 (7.1) Oxybutynin 4 (14.2)
Citalopram 3 (10.7) Tolterodine 3 (10.7)
Flavoxate 2 (7.1)
ARS=Anticholinergic risk scale
Table 3: Side‑effects of anticholinergic drugs
Symptoms* n (%)
Drowsiness 18 (65)
Dry mouth 15 (53)
Dry eyes 14 (50)
Constipation 11 (39)
Blurred vision 11 (39)
Urinary hesitancy 8 28)
Confusion 6 (21)
*Multiple response
Yayla, et al.: Drugs with anticholinergic side‑effects
21Nigerian Journal of Clinical Practice • Jan-Feb 2015 • Vol 18 • Issue 1
drug scale as a measure of drug‑related anticholinergic burden: 
Associations with serum anticholinergic activity. J Clin Pharmacol 2006; 
46:1481‑6.
21. American Geriatrics Society Updated Beers Criteria for Potentially Inappropriate 
Medication Use in Older Adults. J Am Geriatr Soc 2012 Apr; 60:616‑31. 
22. Chew ML, Mulsant BH, Pollock BG, Lehman ME, Greenspan A, 
Mahmoud RA, et al. Anticholinergic activity of 107 medications commonly 
used by older adults. J Am Geriatr Soc 2008;56:1333‑41.
23. Castelino RL, Bajorek BV, Chen TF. Targeting suboptimal prescribing in the 
elderly: A review of the impact of pharmacy services. Ann Pharmacother 
How to cite this article: Yayla EM, Yavuz E, Bilge U, Keskin A, Binen E. 
Drugs with anticholinergic side-effects in primary care. Niger J Clin Pract 
2015;18:18-21.
Source of Support: Nil, Conflict of Interest: None declared.
2009;43:1096‑106.
24. Ruthazer R, Lipsitz LA. Antidepressants and falls among elderly people in 
long‑term care. Am J Public Health 1993;83:746‑9.
Announcement
iPhone App
A free application to browse and search the journal’s content is now available for iPhone/iPad. 
The application provides “Table of Contents” of the latest issues, which are stored on the device 
for future offline browsing. Internet connection is required to access the back issues and search 
facility. The application is Compatible with iPhone, iPod touch, and iPad and Requires iOS 3.1 or 
later. The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/
id458064375?ls=1&mt=8. For suggestions and comments do write back to us.
